Sarbassov is working on a new drug for KRAS-mutant types of cancer. The drug has already passed the first stage of human trials on a group of 15 cancer patients. As a result, all of them observed a halt in the growth of cancer cells, and some even saw a decrease. Read more about the research from Informburo, Jibek Joly, 24.kz, Liter, Kazinform, and others.
×
Still have questions?
Search studies, locations, and peoplePopular:
Recent Searches:
